Lower expression of CD32b (FcγRIIb), an inhibitory receptor of B cells, was identified on IgM+ B cell subsets in females with MS or CIS compared to normal healthy individuals and was associated with anti-EBV viral capsid antigen IgM antibodies and increased B cell stimulating factor serum levels. Here, CD40LG is linked to myeloid sarcoma.